Waters’ new AI tool targets one of the pharmaceutical industry’s most tedious tasks
Article excerpt
Highlighted: the sentence this signal was extracted from
Brook Colangelo, chief information officer at Waters Corp., says the lab equipment company's newest artificial intelligence tool can help drugmakers speed up their quality testing processes. On Wednesday, Waters debuted a new AI-powered integration called Peak Integration into its Empower software platform to drastically reduce manual interventions traditionally performed by scientists for quality assurance (QA) and quality control (QC) in drug discovery and manufacturing. These QA/QC processes ensure medicines are safe, effective, and compliant with the Food and Drug Administration and other regulatory standards. Waters says that the new AI and machine learning capabilities within Empower - which has 500,000 users and supports the release of popular drugs ranging from aspirin to Wegovy - can reduce manual interventions by 95%. Waters also says that the new AI feature improves testing accuracy by 76% and is 50% faster than the prior process. "The advancements here are around how we take automation and how we take AI to help unlock more human potential in the scientists that are using this technology," says Colangelo, who has served as CIO at Waters since 2018. The latest AI/ML innovation from Waters required a bit of patience. Waters worked closely with an undisclosed, top-ten pharmaceutical company for about one-and-a-half years, with much of that time dedicated to securing...
Keep reading with a free account
The rest of this article, and every signal for Waters, is in your free account.
